Thiophanate Methyl Plus EtridiazoleMethyl Plus Etridiazole

Keyword(s):  
2013 ◽  
Vol 12 (1) ◽  
pp. 85-96 ◽  
Author(s):  
Iuliana Mihaela Lazar ◽  
Daniela Nicuta ◽  
Nicoleta Badaluta ◽  
Gabriel Lazar
Keyword(s):  

2000 ◽  
Vol 66 (1) ◽  
pp. 82-85 ◽  
Author(s):  
Shuhei TANAKA ◽  
Nobue KAMEGAWA ◽  
Shin-ichi ITO ◽  
Mitsuro KAMEYA-IWAKI

Plant Disease ◽  
2021 ◽  
Author(s):  
Leslie Amanda Holland ◽  
Renaud Travadon ◽  
Daniel P. Lawrence ◽  
Mohamed Taieb Nouri ◽  
Florent P Trouillas

Almond trunk and branch canker diseases constitute a major cause of tree mortality in California. Numerous fungal pathogens have been associated with these canker diseases and pruning wounds act as major infection courts. Prior to this study, there were no products registered in California for the management of these diseases. In this study, fungicidal products including synthetic chemistries, biocontrols, paint and a sealant were evaluated for preventing fungal pathogen infection via pruning wounds. In four field trials conducted over two dormant seasons, sixteen pruning wound treatments were tested using hand-held spray applications, against five almond canker pathogens, namely Botryosphaeria dothidea, Neofusicoccum parvum, Cytospora sorbicola, Ceratocystis destructans, and Eutypa lata. The fungicide thiophanate-methyl (Topsin M) provided 82% overall disease prevention against four fungal pathogens. The biological control agent, Trichoderma atroviride SC1 (Vintec), tested at three application rates, resulted in 90 to 93% protection of pruning wounds in field trials, and for individual pathogens ranged from 81-100% protection for the three rates. At the time of this publication, Vintec is being considered for registration as a biological control product for the prevention of almond canker diseases, while Topsin M is recommended to growers for the prevention of almond canker diseases. This research indicates that effective protection of pruning wounds from infection by almond canker pathogens can be achieved with a one-time spray application of thiophanate-methyl or the biocontrol, T. atroviride SC1 (recommended 2 g/liter) after pruning.


1977 ◽  
Vol 15 (3-4) ◽  
pp. 141-147 ◽  
Author(s):  
Toshio MATSUSHITA ◽  
Mitsuki YOSHIOKA ◽  
Koji AOYAMA ◽  
Yoshiki ARIMATSU ◽  
Shigeru NOMURA

2017 ◽  
Vol 4 (1) ◽  
pp. 160866 ◽  
Author(s):  
Hudson V. V. Tomé ◽  
Gabryele S. Ramos ◽  
Micaele F. Araújo ◽  
Weyder C. Santana ◽  
Gil R. Santos ◽  
...  

Bees are key pollinators whose population numbers are declining, in part, owing to the effects of different stressors such as insecticides and fungicides. We have analysed the susceptibility of the Africanized honeybee, Apis mellifera , and the stingless bee, Partamona helleri, to commercial formulations of the insecticides deltamethrin and imidacloprid. The toxicity of fungicides based on thiophanate-methyl and chlorothalonil were investigated individually and in combination, and with the insecticides. Results showed that stingless bees were more susceptible to insecticides than honeybees. The commercial fungicides thiophanate-methyl or chlorothalonil caused low mortality, regardless of concentration; however, their combination was as toxic as imidacloprid to both species, and over 400-fold more toxic than deltamethrin for A. mellifera . There were highly synergistic effects on mortality caused by interactions in the mixture of imidacloprid and the fungicides thiophanate-methyl, chlorothalonil and the combined fungicide formulation in A. mellifera, and also to a lesser extent in P. helleri . By contrast, mixtures of the deltamethrin and the combined fungicide formulation induced high synergy in P. helleri , but had little effect on the mortality of A. mellifera . Differences in physiology and modes of action of agrochemicals are discussed as key factors underlying the differences in susceptibility to agrochemicals.


Author(s):  
Isabela Aparecida Giordani ◽  
Eduarda Busatta ◽  
Luís Carlos Iuñes de Oliveira Filho ◽  
Dilmar Baretta ◽  
Camila Kissmann ◽  
...  

  Pesticides are widely used in the agricultural sector to control and prevent pests and diseases. The use of these products can adversely affect non-target organisms that have a significant role in the soil, such as earthworms. This study evaluated the toxicity of the commercial formulation of the fungicide Comet® (active ingredient – a.i. pyraclostrobin) at concentrations of 0.08, 0.17, 0.35, 0.70, 1.40 and 2.80 mg of the commercial formulation kg-1 soil and the fungicide + insecticide Standak®Top (a.i. pyraclostrobin + thiophanate-methyl + fipronil) at concentrations of 0.05, 0.10, 0.20, 0.60, 1.20 and 2.40 mg of the commercial formulation kg-1 soil, plus the control treatment, to Eisenia andrei in Tropical Artificial Soil (TAS) by means of standardized tests.


2020 ◽  
Vol 7 (3) ◽  
pp. 138-143
Author(s):  
A. J. Deshmukh ◽  
◽  
A. N. Sabalpara ◽  
R. P. Bambharolia ◽  
◽  
...  

The experiment was conducted to perceive the effect of fungicidal seed treatment on seed borne diseases of green gram on susceptible cv. GM-3 with nine different fungicides. Results revealed that dry seed treatment with either mix formulation of carbendazim + mancozeb or thiophanate methyl or carbendazim @ 2.5 g kg-1 seeds is very effective in field to control Macrophomina leaf blight, Alternaria leaf spot and Anthracnose diseases. Two years pooled data indicated that PDI of Macrophomina leaf bilght was significantly lower in dry seed treatment with carbendazim + mancozeb (0.99%, 12.90%) which was statistically at par with thiophanate methyl (1.54%, 13.80%) followed by carbendazim (0.99%, 14.06%) at 35 and 65 DAS, respectively. Two years pooled data of Alternaria leaf spot indicated that the PDI of was significantly lower in dry seed treatment with carbendazim + mancozeb (2.64%, 11.15%) which was statistically at par with thiophanate methyl (2.74%, 11.30%) followed by carbendazim (2.84%, 11.37%) at 35 and 65 DAS. Two years pooled data of Anthracnose disease indicated that the PDI of Anthracnose was significantly lower in dry seed treatment with carbendazim + mancozeb (0.81%, 6.71%).


Sign in / Sign up

Export Citation Format

Share Document